Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal ...

In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, Singapore.

COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker ...

The divestiture of the Czech facility follows U.S.-based Novavax's licensing deal worth at least $1.2 billion with French ...

IGM Biosciences has pivoted from cancer therapeutics to autoimmune diseases despite setbacks, showing a 25% stock increase since last October. Click for more on IGMS.

The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

Novavax sells manufacturing facility to Novo Nordisk for $200M, enabling Novavax to advance growth strategy and drive value ...

With the purchase of a plant in the Czech Republic, Novo Nordisk is saying “jak se máš” to hundreds of new employees—and ...

In 2024, domestic and foreign equity holders sold shares worth over $30 billion via block deals, showcasing sustained ...

The "North America Orthobiologics Market Outlook to 2033 - Orthobiologics, Cartilage Repair and Others" report has been added to ResearchAndMarkets.com's offering.The North American orthobiologics ...

Maze Therapeutics has completed a Series D financing round, raising $115m to propel the development of its lead candidates, ...

The global hemostasis testing systems market is poised for substantial growth, with a projected value surge from USD 2,149.3 million in 2023 to USD 3,666 million by 2033. This anticipated expansion is ...